{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:18:19Z","timestamp":1785871099298,"version":"3.56.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.aprim.2022.102462","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T04:57:58Z","timestamp":1669179478000},"page":"102462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S1","title":["Prevenci\u00f3n de las enfermedades infecciosas. Actualizaci\u00f3n en vacunas PAPPS 2022"],"prefix":"10.1016","volume":"54","author":[{"given":"Susana","family":"Mart\u00edn Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Luisa","family":"Morat\u00f3 Agust\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Pilar","family":"Javierre Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coro","family":"S\u00e1nchez Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Schwarz Chavarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aldaz Herce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Garc\u00eda Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Javier","family":"G\u00f3mez Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Guti\u00e9rrez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2022.102462_bib0350","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.aprim.2020.08.001","article-title":"Prevenci\u00f3n de las enfermedades infecciosas. Actualizaci\u00f3n en vacunas, 2020","volume":"52","author":"Schwarz","year":"2020","journal-title":"Aten Primaria."},{"key":"10.1016\/j.aprim.2022.102462_bib0355","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses","volume":"16","author":"Crooke","year":"2019","journal-title":"Immun Ageing."},{"key":"10.1016\/j.aprim.2022.102462_bib0360","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00281-020-00806-z","article-title":"The interplay between immunosenescence and age-related diseases","volume":"42","author":"Barb\u00e9-Tuana","year":"2020","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.aprim.2022.102462_bib0365","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.4110\/in.2019.19.e37","article-title":"Aging and the immune system: The impact of immunosenescence on viral infection, immunity and vaccine immunogenicity","volume":"19","author":"Oh","year":"2019","journal-title":"Immune Netw."},{"key":"10.1016\/j.aprim.2022.102462_bib0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coph.2018.03.014","article-title":"Adjuvant strategies to improve vaccination of the elderly population","volume":"41","author":"Weinberger","year":"2018","journal-title":"Curr Opin Pharmacol."},{"key":"10.1016\/j.aprim.2022.102462_bib0375","unstructured":"Consejo Interterritorial del Sistema Nacional de Salud. Calendario com\u00fan de vacunaci\u00f3n a lo largo de toda la vida 2022. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional del SNS. Ministerio de Sanidad, febrero 2022 [consultado 28 Mar 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-ycoberturas\/docs\/CalendarioVacunacion_Todalavida.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0380","unstructured":"Consejo Interterritorial del Sistema Nacional de Salud. Ponencia de Programa y Registro de Vacunaciones. Recomendaciones de vacunaci\u00f3n frente a la gripe. Temporada 2021-22 [consultado 27 Mar 2022].Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/programasDeVacunacion\/docs\/Recomendaciones_vacunacion_gripe.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0385","unstructured":"European Centre for Disease Prevention and Control (ECDC). Seasonal influenza \u2014 Annual Epidemiological Report for 2020-2021 [consultado 17 Jun 2022]. Disponible en: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/seasonal-influenza-annual-epidemiological-report-2020-2021"},{"key":"10.1016\/j.aprim.2022.102462_bib0390","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.aprim.2022.102462_bib0395","unstructured":"World Health Organization (?2019)?. Global influenza strategy 2019-2030. World Health Organization. Disponible en: https:\/\/apps.who.int\/iris\/handle\/10665\/311184. Licencia: CC BY-NC-SA 3.0 IGO"},{"key":"10.1016\/j.aprim.2022.102462_bib0400","unstructured":"Vacunas de uso humano comercializadas en Espa\u00f1a [consultado 17 Jun 2022]. Disponible en: https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/vacunas\/comb_viricas\/"},{"key":"10.1016\/j.aprim.2022.102462_bib0405","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(22)00383-X","article-title":"SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses","volume":"399","author":"Swets","year":"2022","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2022.102462_bib0410","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal capsules and their types: Past, present, and future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.aprim.2022.102462_bib0415","doi-asserted-by":"crossref","first-page":"e3778","DOI":"10.1093\/cid\/ciaa1483","article-title":"Nationwide trends of invasive pneumococcal disease in Spain (2009-2019) in children and adults during the pneumococcal conjugate vaccine era","volume":"73","author":"De Miguel","year":"2021","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.aprim.2022.102462_bib0420","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.rmed.2018.02.007","article-title":"Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review","volume":"137","author":"Torres","year":"2018","journal-title":"Respir Med."},{"key":"10.1016\/j.aprim.2022.102462_bib0425","doi-asserted-by":"crossref","first-page":"e0169368","DOI":"10.1371\/journal.pone.0169368","article-title":"Effectiveness of the 23-valent Pneumococcal Polysaccharide Vaccine (PPV23) against pneumococcal disease in the elderly: Systematic review and meta-analysis","volume":"12","author":"Falkenhorst","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.aprim.2022.102462_bib0430","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cmi.2019.10.034","article-title":"Emerging non-PCV13 serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain","volume":"26","author":"Gonz\u00e1lez-D\u00edaz","year":"2020","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.aprim.2022.102462_bib0435","doi-asserted-by":"crossref","first-page":"7744","DOI":"10.1016\/j.vaccine.2018.05.026","article-title":"The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage","volume":"36","author":"Ciruela","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.aprim.2022.102462_bib0440","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/cid\/ciy872","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine among adults: A systematic review and meta-analysis","volume":"69","author":"Vadlamudi","year":"2019","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.aprim.2022.102462_bib0445","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/thoraxjnl-2018-211767","article-title":"Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: Implications for adult vaccination","volume":"74","author":"Hanquet","year":"2019","journal-title":"Thorax."},{"key":"10.1016\/j.aprim.2022.102462_bib0450","unstructured":"Grupo de trabajo vacunaci\u00f3n frente a EMI de la Ponencia de Programa y Registro de Vacunaciones. Recomendaciones de vacunaci\u00f3n frente a enfermedad meningoc\u00f3cica invasiva. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Consumo y Bienestar Social; marzo 2019 [consultado 27 Mar 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/Recomendaciones_Vacunacion_Meningococo.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0455","unstructured":"Ministerio de Sanidad. Direcci\u00f3n General de Salud P\u00fablica, Calidad e Innovaci\u00f3n. Vacunaci\u00f3n frente a MenACWY a adolescentes y j\u00f3venes (catch up). Preguntas y respuestas dirigidas a profesionales sanitarios; enero 2020 [consultado 27 Mar 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/programasDeVacunacion\/adolescentes-meningo\/docs\/MenACWY_ProfSanitarios.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0460","unstructured":"Ponencia de Programas y Registro de Vacunaciones. Adenda. Modificaci\u00f3n en \u00abRecomendaciones de utilizaci\u00f3n de la vacuna frente a enfermedad meningoc\u00f3cica por serogrupo B\u00bb. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad; 2015 [consultado 10 Abr 2022]. Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/comoTrabajamos\/docs\/Adenda MenB situacEspeciales.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0465","unstructured":"Ministerio de Sanidad. Vacunas y Programa de vacunaci\u00f3n. Coberturas de Vacunaci\u00f3n [consultado 28 Mar 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/coberturas\/docs\/Tabla7.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0470","unstructured":"Consejo Interterritorial del Sistema Nacional de Salud. Vacunaci\u00f3n espec\u00edfica en personas adultas (\u226518 a\u00f1os) con condiciones de riesgo 2022. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del SNS. Ministerio de Sanidad, febrero de 2022 [consultado 28 Mar 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/docs\/CalendarioVacunacion_GRadultos.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0475","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1901229","article-title":"Vaccination of infants with meningococcal group B vaccine (4CMenB) in England","volume":"382","author":"Ladhani","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.aprim.2022.102462_bib0480","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1016\/j.vaccine.2019.06.021","article-title":"Impact of a mass vaccination campaign against serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch","volume":"37","author":"Deceuninck","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.aprim.2022.102462_bib0485","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1001\/jama.2020.20449","article-title":"Association of use of a meningococcus group B vaccine with group B invasive meningococcal disease among children in Portugal","volume":"324","author":"Rodrigues","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.aprim.2022.102462_bib0490","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/vaccines8030469","article-title":"Effectiveness and impact of the 4CMenB vaccine against group B meningococcal disease in two Italian regions using different vaccination schedules: A five-year retrospective observational study (2014-2018)","volume":"8","author":"Azzari","year":"2020","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.aprim.2022.102462_bib0495","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1093\/cid\/ciaa1636","article-title":"Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents","volume":"73","author":"McMillan","year":"2021","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.aprim.2022.102462_bib0500","unstructured":"AEMPS. Fichas t\u00e9cnicas de vacunas [consultado 27 Mar 2022]. Disponible en: https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/vacunas\/"},{"key":"10.1016\/j.aprim.2022.102462_bib0505","first-page":"CD009069","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.aprim.2022.102462_bib0510","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: Updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2022.102462_bib0515","unstructured":"Cox JT, Palefsky JM. Human papillomavirus vaccination. UpToDate. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc [actualizado en diciembre 2021; consultado 7 Abr 2022]. Disponible en: https:\/\/www.uptodate.com\/contents\/human-papillomavirusvaccination?search=indicaciones%20vacuna%20VPH&source=search_result&selectedTitle=1\u223c87&u sage_type=default&display_rank=1"},{"key":"10.1016\/j.aprim.2022.102462_bib0520","unstructured":"World Health Organisation. Cervical Cancer. Ginebra: OMS; 2022 [actualizado en febrero de 2022; consultado 2 Abr 2022]. Disponible en: https:\/\/www.who.int\/news-room\/factsheets\/detail\/cervical-cancer"},{"key":"10.1016\/j.aprim.2022.102462_bib0525","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. November 2020. Ginebra: OMS; 2020. Disponible en: https:\/\/www.who.int\/publications\/i\/item\/9789240014107"},{"key":"10.1016\/j.aprim.2022.102462_bib0530","unstructured":"Ministerio de Sanidad. Vacunas y Programa de vacunaci\u00f3n. Coberturas de Vacunaci\u00f3n [consultado 28 Mar 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario -ycoberturas\/coberturas\/home.htm"},{"key":"10.1016\/j.aprim.2022.102462_bib0535","unstructured":"Comit\u00e9 Asesor de Vacunas (CAV-AEP). Virus del papiloma humano. Manual de vacunas en l\u00ednea de la AEP. Madrid: AEP; marzo de 2022 [consultado 19 Abr 2022]. Disponible en: http:\/\/vacunasaep.org\/documentos\/manual\/cap-42"},{"key":"10.1016\/j.aprim.2022.102462_bib0540","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: A register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.aprim.2022.102462_bib0545","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/aje\/kwz253","article-title":"Effectiveness of 1, 2, and 3 doses of human papillomavirus vaccine against high-grade cervical lesions positive for human papillomavirus 16 or 18","volume":"189","author":"Johnson Jones","year":"2020","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.aprim.2022.102462_bib0550","unstructured":"European Centre for Disease Prevention and Control. Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction, 2020. Stockholm: ECDC; 2020. Disponible en: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Guidance-on-HPV-vaccination-in-EUcountries2020-03-30.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0555","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.vaccine.2019.12.017","article-title":"Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials","volume":"38","author":"Whitworth","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.aprim.2022.102462_bib0560","unstructured":"World Health Organisation. The Strategic Advisory Group of Experts on Immunization (SAGE). Ginebra: OMS; 2022. One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer. 11 April 2022 [consultado 11 Abr 2022]. Disponible en: https:\/\/www.who.int\/news\/item\/11-04-2022-one-dose-human-papillomavirus-(hpv)-vaccine-offerssolid-protection-against-cervical-cancer"},{"key":"10.1016\/j.aprim.2022.102462_bib0565","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/14760584.2018.1548282","article-title":"Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials","volume":"17","author":"Arbyn","year":"2018","journal-title":"Expert Rev Vaccines."},{"key":"10.1016\/j.aprim.2022.102462_bib0570","unstructured":"OMS. Organizaci\u00f3n Mundial de la Salud. Coronavirus (COVID-19) [consultado 27 Feb 2022]. Disponible en: https:\/\/covid19.who.int\/"},{"key":"10.1016\/j.aprim.2022.102462_bib0575","unstructured":"ECDC. Centro Europeo para la Prevenci\u00f3n y Control de Enfermedades. COVID-19 [consultado 19 Feb 2022]. Disponible en: https:\/\/www.ecdc.europa.eu\/en\/covid-19"},{"key":"10.1016\/j.aprim.2022.102462_bib0580","unstructured":"Ministerio de Sanidad. Enfermedad por el nuevo coronavirus, COVID-19 [consultado 19 Feb 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov\/home.htm"},{"key":"10.1016\/j.aprim.2022.102462_bib0585","unstructured":"Ministerio de Sanidad. Estrategia de vacunaci\u00f3n COVID-19 en Espa\u00f1a [consultado 1 Abr 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov\/documentos\/Informe_GIV_comunicacion_20220401.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0590","first-page":"442","article-title":"Efectividad y seguridad de las vacunas para el SARS-CoV-2 actualmente disponibles","volume":"28","author":"G\u00f3mez Marco","year":"2021","journal-title":"FMC"},{"key":"10.1016\/j.aprim.2022.102462_bib0595","article-title":"Vigilancia y epidemiolog\u00eda del herpes z\u00f3ster en Espa\u00f1a","volume":"95","author":"Masa-Calles","year":"2021","journal-title":"Rev Esp Salud P\u00fablica."},{"key":"10.1016\/j.aprim.2022.102462_bib0600","unstructured":"Grupo de trabajo de vacunaci\u00f3n frente a herpes z\u00f3ster de la Ponencia de Programa y Registro de Vacunaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, marzo 2021 [consultado 7 Feb 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/en\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/programasDeVacunacion\/docs\/HerpesZoster_RecomendacionesVacunacion.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0605","unstructured":"Centro Nacional de Epidemiolog\u00eda. CIBERESP. Instituto de Salud Carlos III. Informe epidemiol\u00f3gico sobre la situaci\u00f3n del Herpes Z\u00f3ster en Espa\u00f1a, 1998-2018. Madrid, agosto 2020 [consultado 7 Feb 2022]. Disponible en: https:\/\/www.isciii.es\/QueHacemos\/Servicios\/VigilanciaSaludPublicaRENAVE\/EnfermedadesTransmisibles\/Documents\/archivos%20A-Z\/HERPES%20ZOSTER\/Informe_HZ_Espa%C3%B1a_1998-2018.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0610","unstructured":"Preguntas y respuestas m\u00e1s frecuentes sobre la vacunaci\u00f3n frente Herpes Z\u00f3ster. Direcci\u00f3n General de Salud P\u00fablica. Consejer\u00eda de Sanidad. Comunidad de Madrid. 29 de abril de 2022 [consultado 7 Feb 2022]. Disponible en: https:\/\/www.comunidad.madrid\/sites\/default\/files\/doc\/sanidad\/prev\/2022.04.29_preguntas_y_respuestas_vacunacion_hz.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0615","unstructured":"Ministerio de Sanidad. Protocolo para la detecci\u00f3n precoz y manejo de casos ante la alerta de viruela de los monos (Monkeypox) en Espa\u00f1a [actualizado a 16 de junio de 2022, consultado 27 Jun 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/alertaMonkeypox\/docs\/ProtocoloMPX_2022.06.16.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0620","unstructured":"CDC. Viruela. Disponible en: https:\/\/www.cdc.gov\/smallpox\/clinicians\/vaccination.html"},{"key":"10.1016\/j.aprim.2022.102462_bib0625","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.aprim.2022.102462_bib0630","unstructured":"ECDC. Monkeypox multi-country outbreak. Rapid risk assessment. 23 May 2022. Disponible en: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Monkeypox-multi-country-outbreak.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0635","unstructured":"Ministerio de Sanidad. Centro de Coordinaci\u00f3n de Alertas y Emergencias Sanitarias. Informe de situaci\u00f3n 17 de junio 2022. Alerta sobre infecci\u00f3n de viruela de los monos en Espa\u00f1a y otros pa\u00edses no end\u00e9micos. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/alertaMonkeypox\/docs\/Informe_de_situacion_MPX_20220617.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0640","unstructured":"Ministerio de Sanidad. Consejo Interterritorial del Sistema Nacional de Salud. \u00abRecomendaciones de vacunaci\u00f3n en el brote actual de viruela del mono\u00bb. Aprobado por la Comisi\u00f3n de Salud P\u00fablica en la reuni\u00f3n mantenida el 9 de junio de 2022. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/MonkeyPox\/docs\/Propuesta_vacunacion_Monkeypox.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0645","unstructured":"Manual MSD. Disponible en: https:\/\/www.msdmanuals.com\/es-es\/professional\/enfermedades-infecciosas\/poxvirus\/viruela?query=Vacuna%20contra%20la%20viruela#v1023288_es"},{"key":"10.1016\/j.aprim.2022.102462_bib0650","unstructured":"European Medicines Agency (EMA). Imvanex - Smallpox vaccine (Live Modified Vaccinia Virus Ankara). Amsterdam: EMA; 2022. Disponible en: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/imvanex"},{"key":"10.1016\/j.aprim.2022.102462_bib0655","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J Virol."},{"key":"10.1016\/j.aprim.2022.102462_bib0660","unstructured":"Ministerio de Sanidad. Vacunaci\u00f3n en personal sanitario. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/vacunas\/docs\/Vacunacion_sanitarios.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0665","unstructured":"Ministerio de Sanidad. Resultados coberturas de vacunaci\u00f3n a\u00f1o 2020. Coberturas vacunales en profesionales sanitarios. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/calendario-y-coberturas\/coberturas\/docs\/Tabla13.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0670","unstructured":"Ministerio de Sanidad. Vacunas y Programas de Vacunaci\u00f3n. Embarazada [consultado 3 Abr 2022]. Disponible en: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/programasDeVacunacion\/embarazadas\/mujeres\/embarazadas.htm"},{"key":"10.1016\/j.aprim.2022.102462_bib0675","unstructured":"Recomendaciones FACME para la vacunaci\u00f3n frente a COVID-19 en mujeres embarazadas [actualizado 2 diciembre 2021; consultado 3 Abr 2022]. Dispoible en: https:\/\/facme.es\/wp-content\/uploads\/2021\/12\/20211202-FAC-Embarazadas-Recomendaciones-para-la-vacunaci\u00f3n-frente-a-COVID-19-.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0680","unstructured":"Goodman, T. Update on WHO Interim Recommendations on COVID-19 Vaccination of Pregnant and Lactating Women. WHO 2022 [consultado 3 Abr 2022]. Disponible en: https:\/\/cdn.who.int\/media\/docs\/default-source\/2021-dha-docs\/update-on-who-interim-recommendations-on-c-19-vaccination-for-pregnant-and-lactating-women-70-.pdf"},{"key":"10.1016\/j.aprim.2022.102462_bib0685","first-page":"100718","article-title":"Embarazo y vacunaci\u00f3n COVID-19","volume":"49","author":"Trilla Garc\u00eda","year":"2022","journal-title":"Clin Invest Ginecol Obstet."},{"key":"10.1016\/j.aprim.2022.102462_bib0690","unstructured":"Grupo de trabajo vacunaci\u00f3n en poblaci\u00f3n adulta y grupos de riesgo de la Ponencia de Programa y Registro de Vacunaciones. Vacunaci\u00f3n en grupos de riesgo de todas las edades y en determinadas situaciones. Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Consumo y Bienestar Social, julio 2018. Disponible en: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/VacGruposRiesgo\/docs\/VacGruposRiesgo_todas_las_edades.pdf"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722001822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656722001822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:04:15Z","timestamp":1759323855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656722001822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":69,"alternative-id":["S0212656722001822"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102462","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevenci\u00f3n de las enfermedades infecciosas. Actualizaci\u00f3n en vacunas PAPPS 2022","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2022.102462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102462"}}